Markets:

Overview

News

Currencies

International

Treasuries

Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

3.340 +0.060 (+1.83%)

Official Closing Price Updated: 8:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cryo-Cell International, Inc. - Common Stock

Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American

May 08, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks

April 28, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results

April 14, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Receives NYSE American Continued Listing Notice

March 12, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Looking Into Cryo-Cell International's Return On Capital Employed ↗

April 24, 2023

Via Benzinga

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025

February 27, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

October 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell International, Inc. Provides Dividend Update

August 14, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results

July 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

May 08, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results

April 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024

February 28, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives

January 29, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

October 30, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

October 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024 ↗

July 15, 2024

CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

July 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 26, 2024

Via Benzinga

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024 ↗

April 15, 2024

CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

April 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

March 25, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

February 28, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

October 12, 2023

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

July 14, 2023

From Cryo-Cell International, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 26, 2023

Via Benzinga

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

April 21, 2023

From Cryo-Cell International, Inc.

Via Business Wire

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗

October 05, 2022

Losers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 04, 2022

Gainers

Via Benzinga

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.